Sofia Agelaki

7.4k citations
216 papers · 5.0k indexed · h-index 40

Sofia Agelaki

204 papers receiving 4.9k citations

Peers

Sofia Agelaki
Comparison fields: 5 of 122
  • Oncology 3.6k
  • Cancer Research 1.9k
  • Pulmonary and Respiratory Medicine 1.5k
  • Microbiology 16
  • Behavioral Neuroscience 76
Replace Tetsunari Oyama with:
Tetsunari Oyama Japan
Giovanni Luca Ceresoli Italy
Vincent A. Memoli United States
Ana Arance Spain
Miguel A. Villalona‐Calero United States
Brendan D. Curti United States
E. Brambilla France
Peter S. Hammerman United States
Antonio Gualberto United States
Joel W. Neal United States
Sofia Agelaki relative to Tetsunari Oyama Japan Tetsunari Oyama's profile →
Citations per field
00.5×6.9×
Tetsunari Oyama · 1×
Citations per year

Countries citing papers authored by Sofia Agelaki

Since Specialization
Citations

This map shows the geographic impact of Sofia Agelaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Agelaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Agelaki more than expected).

Fields of papers citing papers by Sofia Agelaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Agelaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Agelaki. The network helps show where Sofia Agelaki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sofia Agelaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofia Agelaki Line = papers co-authored together Sofia Agelaki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20260
2 20250
3 20250
4 20250
5 20243
6 20241
7 20246
8 202210
9 202115
10 2018146
11 201819
12 201864
13 201674
14 20141
15 201385
16 2008125
17 200842
18 200824
19 200763
20 20015

About Sofia Agelaki

Sofia Agelaki is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 216 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (52 papers), Cancer Cells and Metastasis (48 papers), Lung Cancer Treatments and Mutations (48 papers), Lung Cancer Research Studies (48 papers), Cancer Genomics and Diagnostics (27 papers), Colorectal Cancer Treatments and Studies (24 papers), HER2/EGFR in Cancer Research (24 papers) and Neutropenia and Cancer Infections (22 papers). The work is most often cited by research in Oncology (3.6k citations), Cancer Research (1.9k citations) and Pulmonary and Respiratory Medicine (1.5k citations). Sofia Agelaki has collaborated with scholars based in Greece, United States and Sweden. Frequent co-authors include Dimitris Mavroudis, Vassilis Georgoulias, Galatea Kallergi, Vassilis Georgoulias, Maria A. Papadaki, Kostas Kalbakis, Dimitriοs Mavroudis, Panayiotis A. Theodoropoulos, D. Mavroudis and Eleni Politaki. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Annals of Oncology, Cancers and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026